Holen Sie sich die Stockscreener-App
0.5854
3.21%
-0.0196
Schlusskurs vom Vortag:
$0.605
Offen:
$0.5989
24-Stunden-Volumen:
151.03K
Relative Volume:
0.03
Marktkapitalisierung:
$19.49M
Einnahmen:
$570.00K
Nettoeinkommen (Verlust:
$-26.74M
KGV:
-0.8982
EPS:
-0.6517
Netto-Cashflow:
$-33.12M
1W Leistung:
+1.81%
1M Leistung:
+2.02%
6M Leistung:
+84.44%
1J Leistung:
-75.08%
1-Tages-Spanne:
$0.58
$0.5989
1-Wochen-Bereich:
$0.5646
$0.608
52-Wochen-Spanne:
$0.2805
$2.5699
Vyne Therapeutics Inc Stock (VYNE) Company Profile
Firmenname
Vyne Therapeutics Inc
Sektor
Branche
Telefon
800-775-7936
Adresse
685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER
Compare VYNE vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VYNE
Vyne Therapeutics Inc
|
0.5856 | 20.14M | 570.00K | -26.74M | -33.12M | -0.6517 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.79 | 123.47B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
781.36 | 83.60B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
748.96 | 46.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
318.93 | 43.11B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
298.06 | 34.79B | 4.98B | 69.60M | 525.67M | 0.5198 |
Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-31 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-11-18 | Eingeleitet | BTIG Research | Buy |
| 2021-12-06 | Fortgesetzt | H.C. Wainwright | Buy |
Vyne Therapeutics Inc Aktie (VYNE) Neueste Nachrichten
Vyne Therapeutics Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
Technical Analysis: What analysts say about VYNE Therapeutics Inc stockJuly 2025 Trends & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
VYNE Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
VYNE Should I Buy - Intellectia AI
VYNE: Losses narrowed in 2025 as the company pivots to a merger with Yarrow and exits key R&D programs - TradingView
VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
VYNE Therapeutics (VYNE) to Release Quarterly Earnings on Thursday - Defense World
Aug Analyst Calls: Is Magnite Inc on track to beat earningsWeekly Profit Analysis & Verified Technical Signals - baoquankhu1.vn
How VYNE Therapeutics Inc. stock performs in rate cut cyclesWatch List & Consistent Income Trade Recommendations - mfd.ru
Comparing Qualigen Therapeutics (NASDAQ:QLGN) and VYNE Therapeutics (NASDAQ:VYNE) - Defense World
Why is VYNE Therapeutics Inc. stock going upTrade Signal Summary & Proven Capital Preservation Methods - mfd.ru
VYNE Therapeutics Inc. (NASDAQ:VYNE) Sees Large Decline in Short Interest - Defense World
Published on: 2026-02-14 10:12:41 - mfd.ru
What analysts say about VYNE Therapeutics Inc. stockWeekly Stock Analysis & Accurate Intraday Trading Signals - mfd.ru
Can VYNE Therapeutics Inc. deliver consistent dividendsJuly 2025 Highlights & Detailed Earnings Play Alerts - mfd.ru
Published on: 2026-02-12 18:59:51 - mfd.ru
Can VYNE Therapeutics Inc. benefit from deglobalizationPortfolio Update Report & Capital Efficient Trading Techniques - mfd.ru
Published on: 2026-02-09 22:57:29 - baoquankhu1.vn
What analysts say about VYNE Therapeutics Inc stockEarnings Growth Summary & Smart Money Movement Tracker - baoquankhu1.vn
Portfolio Recap: Why is VYNE Therapeutics Inc stock going upBuy Signal & Reliable Momentum Entry Alerts - baoquankhu1.vn
Trade Report: What is the long term forecast for VYNE Therapeutics Inc stockInflation Watch & High Conviction Buy Zone Alerts - baoquankhu1.vn
Does MTCH stock have upside surprise potentialQuarterly Trade Report & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
VYNE Therapeutics Amends Merger Terms with Yarrow Bioscience - TipRanks
VYNE Therapeutics Signs Amendment to Merger Agreement With Yarrow Bioscience - TradingView
Breakout Zone: Is VYNE Therapeutics Inc stock showing strong momentumTrade Performance Summary & Stock Market Timing Techniques - baoquankhu1.vn
How cyclical is VYNE Therapeutics Inc.’s revenue stream2025 Winners & Losers & Long-Term Growth Portfolio Plans - mfd.ru
Short Interest in VYNE Therapeutics Inc. (NASDAQ:VYNE) Decreases By 55.4% - Defense World
Support Test: Can SunCar Technology Group Inc. scale operations efficientlyMarket Movers & Verified Swing Trading Watchlists - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Block Trades: Is VersaBank a potential multi baggerJuly 2025 Institutional & Technical Buy Zone Confirmations - baoquankhu1.vn
Is Sonoco Products Company exposed to currency risksMarket Growth Report & Verified Entry Point Signals - baoquankhu1.vn
Volume Summary: Is VYNE Therapeutics Inc stock showing strong momentumWeekly Risk Report & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Analysis Recap: What is the long term forecast for VYNE Therapeutics Inc stockQuarterly Growth Report & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Aug Opening: How does CCLDO correlate with NasdaqJuly 2025 Institutional & Technical Buy Zone Confirmations - baoquankhu1.vn
Weekly Earnings: Is SEALPRB stock a value trapJuly 2025 Gainers & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Aug EndMonth: Why is VYNE Therapeutics Inc stock going upWeekly Gains Report & Fast Momentum Entry Tips - baoquankhu1.vn
Is VYNE Therapeutics Inc. stock positioned well for digital economyJuly 2025 Pullbacks & Safe Entry Trade Reports - Улправда
Will VYNE Therapeutics Inc. stock remain a Wall Street favoriteJuly 2025 Trends & AI Enhanced Trading Alerts - Улправда
US Stocks Recap: Will VYNE Therapeutics Inc stock remain a Wall Street favoriteJuly 2025 Gainers & Free Safe Capital Growth Stock Tips - Bộ Nội Vụ
What insider trading reveals about VYNE Therapeutics Inc. stockJuly 2025 Chart Watch & Reliable Breakout Forecasts - ulpravda.ru
VYNE Therapeutics Inc. (NASDAQ:VYNE) Short Interest Down 18.2% in December - Defense World
VYNE Therapeutics Inc. (VYNE) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
VYNE SEC FilingsVyne Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Vyne Therapeutics shares surge on merger deal with Yarrow Bioscience - MSN
Why VYNE Therapeutics Inc. stock remains resilient2025 EndofYear Setup & Entry Point Confirmation Signals - Улправда
VYNE Therapeutics to merge with Yarrow Bioscience, secures $200M financing; shares up - MSN
Halper Sadeh LLC Encourages FOLD, VYNE, HTBK, FMNB Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire
Halper Sadeh LLC Encourages FOLD, VYNE, HTBK, FMNB Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
How VYNE Therapeutics Inc. stock compares to industry benchmarksMarket Sentiment Review & AI Enhanced Market Trend Forecasts - Улправда
Should I hold or sell VYNE Therapeutics Inc. stock in 2025Market Activity Summary & High Conviction Trade Alerts - Улправда
Is VYNE Therapeutics Inc. stock resilient to inflation2025 Market Outlook & AI Based Buy and Sell Signals - Улправда
Finanzdaten der Vyne Therapeutics Inc-Aktie (VYNE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):